Latest
New treatment for multidrug-resistant TB shows 85% effectiveness
New treatment regimens for multidrug-resistant tuberculosis (MDR-TB) have shown early effectiveness in 85 percent of patients in a cohort that included many people with serious comorbidities that would have excluded them from clinical trials, according to the results of a new international study. The results, based on observational data from …
Is it time to resume COVID restrictions in some safe states?
There may be new trouble ahead for states that had gotten COVID-19 under control after the March and April surges but are now seeing case numbers drift up. The movement may be an early signal that governors and other local officials need to take modest steps to head off the …
Treating children for worms yields health and financial gains
Children who receive sustained treatment against common parasitic infections grow up to achieve a higher standard of living, with long-lasting health and economic benefits that extend to their communities, according to new findings from an international research team. The pioneering 20-year study of Kenyan schoolchildren led by Edward Miguel, an …
Violence and trauma in childhood accelerate puberty
Experiencing adversity early in life has a direct effect on a person’s mental and physical health as they grow, and certain kinds of trauma can affect the pace of aging, according to new Harvard research. In addition to being risk factors for anxiety, depression, and stress, early life experiences like …
Portable clotting agent slows internal bleeding by 97% in mice
When it comes to traumatic injuries, it’s a race against time. A person with major hemorrhage can die from blood loss within minutes. Bleeding from the extremities can be slowed with compression but what about internal bleeding? In a hospital, internal bleeding can be controlled with the transfusion of clotting …
Single-shot COVID-19 vaccine proves successful with primates
A single-shot vaccine for COVID-19 being developed by a group of scientists, led by Beth Israel Deaconess Medical Center (BIDMC) immunologist Dan H. Barouch, has proven successful in tests on primates and could begin phase 3 trials as early as September. The results of the tests on the vaccine, developed …